Inclusion and response criteria for clinical trials in relapsed/refractory acute lymphoblastic leukemia and usefulness of historical control trials

• Nicola Gökbuget,
• Herve Dombret,
• Renato Bassan,
• Martha Wadleigh,
• Michael Doubek,
• Josep Ribera

Affiliations

Nicola Gökbuget

University Hospital, Goethe University, Frankfurt, Germany

Herve Dombret

Hopital Saint-Louis, Paris, France

Renato Bassan

UOC Ematologia, Ospedale dell’Angelo, Mestre-Venezia, Italy

Martha Wadleigh

Dana-Farber Cancer Institute, Boston, MA, USA

Michael Doubek

University Hospital, Brno, Czech Republic, Barcelona, Spain

Josep Ribera

ICO-Hospital Germans Trias I Pujol, Jose Carreras Research Institute, Barcelona, Spain